Annual CFI
-$78.86 M
NaN%
December 31, 2023
Summary
- As of February 7, 2025, RAPP annual cash flow from investing activities is -$78.86 million
- RAPP annual CFI is now at all-time high.
Performance
RAPP Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$53.04 M
+$54.06 M+50.48%
September 30, 2024
Summary
- As of February 7, 2025, RAPP quarterly cash flow from investing activities is -$53.04 million, with the most recent change of +$54.06 million (+50.48%) on September 30, 2024.
- Over the past year, RAPP quarterly CFI has dropped by -$11.12 million (-26.51%).
- RAPP quarterly CFI is now -101901.92% below its all-time high of -$52.00 thousand, reached on September 1, 2023.
Performance
RAPP Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$280.73 M
-$52.99 M-23.27%
September 30, 2024
Summary
- As of February 7, 2025, RAPP TTM cash flow from investing activities is -$280.73 million, with the most recent change of -$52.99 million (-23.27%) on September 30, 2024.
- Over the past year, RAPP TTM CFI has dropped by -$160.01 million (-132.54%).
- RAPP TTM CFI is now -460116.39% below its all-time high of -$61.00 thousand, reached on March 31, 2023.
Performance
RAPP TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
RAPP Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -26.5% | -132.5% |
| 3 y3 years | - | -10000.0% | -10000.0% |
| 5 y5 years | - | -10000.0% | -10000.0% |
RAPP Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | <-9999.0% | +50.5% | <-9999.0% | at low |
| 5 y | 5-year | at high | at low | <-9999.0% | +50.5% | <-9999.0% | at low |
| alltime | all time | at high | at low | <-9999.0% | +50.5% | <-9999.0% | at low |
Rapport Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$53.04 M(-50.5%) | -$280.73 M(+23.3%) |
| Jun 2024 | - | -$107.10 M(+155.5%) | -$227.74 M(+88.6%) |
| Mar 2024 | - | -$41.93 M(-46.7%) | -$120.72 M(+53.1%) |
| Dec 2023 | -$78.86 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | - | -$78.66 M(>+9900.0%) | -$78.86 M(>+9900.0%) |
| Sep 2023 | - | -$52.00 K(-39.5%) | -$199.00 K(+35.4%) |
| Jun 2023 | - | -$86.00 K(+41.0%) | -$147.00 K(+141.0%) |
| Mar 2023 | - | -$61.00 K | -$61.00 K |
FAQ
- What is Rapport Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Rapport Therapeutics?
- What is Rapport Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Rapport Therapeutics?
- What is Rapport Therapeutics quarterly CFI year-on-year change?
- What is Rapport Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Rapport Therapeutics?
- What is Rapport Therapeutics TTM CFI year-on-year change?
What is Rapport Therapeutics annual cash flow from investing activities?
The current annual CFI of RAPP is -$78.86 M
What is the all time high annual CFI for Rapport Therapeutics?
Rapport Therapeutics all-time high annual cash flow from investing activities is -$78.86 M
What is Rapport Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of RAPP is -$53.04 M
What is the all time high quarterly CFI for Rapport Therapeutics?
Rapport Therapeutics all-time high quarterly cash flow from investing activities is -$52.00 K
What is Rapport Therapeutics quarterly CFI year-on-year change?
Over the past year, RAPP quarterly cash flow from investing activities has changed by -$11.12 M (-26.51%)
What is Rapport Therapeutics TTM cash flow from investing activities?
The current TTM CFI of RAPP is -$280.73 M
What is the all time high TTM CFI for Rapport Therapeutics?
Rapport Therapeutics all-time high TTM cash flow from investing activities is -$61.00 K
What is Rapport Therapeutics TTM CFI year-on-year change?
Over the past year, RAPP TTM cash flow from investing activities has changed by -$160.01 M (-132.54%)